Depo Provera Increase Diabetes Risk in Women

Contraception with depo-medroxyprogesterone acetate (DMPA) is associated with an increase in the risk of diabetes in some Latino women with prior gestational diabetes. Dr. Anny Hui Xiang states that, "The finding that DMPA and breast-feeding or DMPA and high triglycerides was associated with increased risk of diabetes in these women was from observational data." "The ultimate way to confirm the risk is to use a randomized controlled clinical trial."

Dr. Xiang, from the University of Southern California Keck School of Medicine, Los Angeles, and colleagues studied 526 Latino women with prior gestational diabetes mellitus who elected to use either DMPA (n = 96) or combination oral contraceptives (n = 430). Median follow-up was about 1 year, with a maximum of 9 years.

The annual incidence rate of diabetes was 19.1% in the DMPA group, the authors report, compared with 11.9% in the combined oral contraceptives group.

Adjustment for baseline body mass index, breast-feeding rates, and family history reduced the increased risk associated with DMPA use from 58% to 18%, the results indicate. Additional adjustment for weight gain during follow-up reduced the increased risk even further, to 7%.

Among women who used DMPA, those with higher than median triglyceride levels had more than double the risk of diabetes, the researchers note, and those who breast-fed also had a similar increase in risk, although this difference was not statistically significant.

"Neither triglycerides nor DMPA use had an important effect to increase diabetes rates alone," the investigators explain, "but together they increased the risk, demonstrating the significant interaction between the two factors."

Dr. Xiang offered this approach to contraceptive choices for Latino women with a history of gestational diabetes: "If breast-feeding, use a non-hormonal approach," and if not breast-feeding "but with relatively high triglycerides, use a non-hormonal method or low-dose combination pills; try to avoid DMPA."

If patients in those categories still elect to use DMPA, "glucose should be carefully monitored, particularly at annual physical exam," she added.

"We want to emphasize the need for family planning in women with prior gestational diabetes," Dr. Xiang concluded. "The worst possible outcome is for a woman to develop diabetes, go undiagnosed and become pregnant, and give birth to a baby with a birth defect. The best way to minimize the risk of this scenario is for women to plan their pregnancies and be evaluated for diabetes before they attempt to conceive."
Diabetes Care 2006;29:613-617.

====================================================

Advertisement
At Advantage/OMC it is our mission to make your job easier by providing your patients with services and products of the highest quality.
We are a full service mail order pharmacy that can offer your patients a full line of prescription medications, blood glucose monitors and supplies, insulin pumps and supplies, as well as impotence devices. The Advantage/OMC alliance provides Major Medical Insurances through Advantage while OMC deals with Medicare Insurance.
https://www.diabetesincontrol.com/ads/omc/dest.php